These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23892183)

  • 1. Models for open innovation in the pharmaceutical industry.
    Schuhmacher A; Germann PG; Trill H; Gassmann O
    Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research and development productivity map: visualization of industry status.
    Shimura H; Masuda S; Kimura H
    J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing R&D models in research-based pharmaceutical companies.
    Schuhmacher A; Gassmann O; Hinder M
    J Transl Med; 2016 Apr; 14(1):105. PubMed ID: 27118048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 9. The development speed paradox: can increasing development speed reduce R&D productivity?
    Lendrem DW; Lendrem BC
    Drug Discov Today; 2014 Mar; 19(3):209-14. PubMed ID: 24051396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to revive breakthrough innovation in the pharmaceutical industry.
    Munos BH; Chin WW
    Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
    Forster SP; Stegmaier J; Spycher R; Seeger S
    Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in the pharmaceutical industry--a case study approach.
    Rusu A; Kuokkanen K; Heier A
    Eur J Pharm Sci; 2011 Oct; 44(3):437-40. PubMed ID: 21782941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reviving an R&D pipeline: a step change in the Phase II success rate.
    Wu SS; Fernando K; Allerton C; Jansen KU; Vincent MS; Dolsten M
    Drug Discov Today; 2021 Feb; 26(2):308-314. PubMed ID: 33129994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value networks identify innovation in 21st century pharmaceutical research.
    Edwards PJ
    Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
    Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
    Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade of innovation in pharmaceutical R&D: the Chorus model.
    Owens PK; Raddad E; Miller JW; Stille JR; Olovich KG; Smith NV; Jones RS; Scherer JC
    Nat Rev Drug Discov; 2015 Jan; 14(1):17-28. PubMed ID: 25503514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for entrepreneurship in R&D in the pharmaceutical industry.
    Douglas FL; Narayanan VK; Mitchell L; Litan RE
    Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.